SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 88 filers reported holding SURFACE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $115,222 | -20.5% | 132,500 | -36.1% | 0.00% | -25.0% |
| Q1 2023 | $145,001 | +12.3% | 207,500 | +31.7% | 0.00% | +33.3% |
| Q4 2022 | $129,150 | -32.0% | 157,500 | -13.7% | 0.00% | -40.0% |
| Q3 2022 | $190,000 | +15.9% | 182,500 | +82.5% | 0.01% | +25.0% |
| Q2 2022 | $164,000 | -44.2% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $294,000 | -59.7% | 100,000 | -5.3% | 0.01% | -64.7% |
| Q3 2020 | $729,000 | -31.4% | 105,600 | -34.9% | 0.02% | -19.0% |
| Q2 2020 | $1,063,000 | +480.9% | 162,100 | +65.2% | 0.02% | +425.0% |
| Q1 2020 | $183,000 | -4.7% | 98,100 | -3.8% | 0.00% | +33.3% |
| Q4 2019 | $192,000 | +53.6% | 102,000 | +15.8% | 0.00% | +50.0% |
| Q3 2019 | $125,000 | -81.5% | 88,100 | -37.9% | 0.00% | -75.0% |
| Q1 2019 | $676,000 | +60.6% | 141,800 | +42.9% | 0.01% | +33.3% |
| Q4 2018 | $421,000 | – | 99,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |